These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38763418)

  • 1. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.
    Fernández-Miranda I; Pedrosa L; González-Rincón J; Espinet B; de la Cruz Vicente F; Climent F; Gómez S; Royuela A; Camacho FI; Martín-Acosta P; Yanguas-Casás N; Domínguez M; Méndez M; Colomo L; Salar A; Horcajo B; Navarro M; García-Cosío M; Piris-Villaespesa M; Llanos M; García JF; Sequero S; Mercadal S; García-Hernández S; Navarro B; Mollejo M; Provencio M; Sánchez-Beato M
    Mod Pathol; 2024 Jul; 37(7):100516. PubMed ID: 38763418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation.
    Li ZH; Zhang MY; Federico M; Civallero M; Manni M; Alonso-Alvarez S; Hou J; Huang HH
    Cancer; 2024 Oct; 130(19):3321-3332. PubMed ID: 38809573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
    PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.
    Carreras J; Ikoma H; Kikuti YY; Miyaoka M; Hiraiwa S; Tomita S; Kondo Y; Ito A; Nagase S; Miura H; Kawada H; Roncador G; Campo E; Hamoudi R; Nakamura N
    Virchows Arch; 2024 Apr; 484(4):657-676. PubMed ID: 38462571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
    Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
    Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.
    Shichijo T; Maruyama D; Yamauchi N; Maeshima AM; Sugano M; Yuda S; Tajima K; Kurihara H; Shimada K; Suzuki T; Toyoda K; Makita S; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Taniguchi H; Minami Y; Izutsu K; Tobinai K
    Cancer Med; 2020 Dec; 9(23):8864-8874. PubMed ID: 33022120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas.
    García-Álvarez M; Alonso-Álvarez S; Prieto-Conde I; Jiménez C; Sarasquete ME; Chillón MC; Medina A; Balanzategui A; Maldonado R; Antón A; Puig N; Rodríguez M; Blanco O; Tamayo P; González-Calle V; Martín A; García-Sanz R; González M; Caballero MD; Alcoceba M
    Blood Cancer J; 2019 Jun; 9(7):52. PubMed ID: 31209206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
    J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic transformation of follicular lymphoma: pathologists' viewpoint.
    Maeshima AM
    J Clin Exp Hematop; 2023; 63(1):12-18. PubMed ID: 36990772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
    Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
    Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
    Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of diffuse large B-cell lymphoma transformed from primary duodenal follicular lymphoma.
    Miyata-Takata T; Takata K; Sato Y; Taniguchi K; Takahashi Y; Ohara N; Yoshino T
    Pathol Int; 2014 Oct; 64(10):527-32. PubMed ID: 25186289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
    Lawrie CH; Chi J; Taylor S; Tramonti D; Ballabio E; Palazzo S; Saunders NJ; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS
    J Cell Mol Med; 2009 Jul; 13(7):1248-60. PubMed ID: 19413891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.
    Berglund M; Enblad G; Thunberg U; Amini RM; Sundström C; Roos G; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
    Mod Pathol; 2007 Jan; 20(1):63-75. PubMed ID: 17170743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
    Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
    J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after histologic transformation of low-grade follicular lymphoma.
    Yuen AR; Kamel OW; Halpern J; Horning SJ
    J Clin Oncol; 1995 Jul; 13(7):1726-33. PubMed ID: 7602362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.
    Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
    Technol Cancer Res Treat; 2023; 22():15330338231180785. PubMed ID: 37551117
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
    Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
    Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.